Rationale: Cystic fibrosis (CF) is a life-shortening, multisystem hereditary disease caused by abnormal chloride transport. CF lung disease is driven by innate immune dysfunction and exaggerated inflammatory responses that contribute to tissue injury. To define the transcriptional profile of this airway immune dysfunction, we performed the first single-cell transcriptome characterization of CF sputum. Objectives: To define the transcriptional profile of sputum cells and its implication in the pathogenesis of immune function and the development of CF lung disease. Methods: We performed single-cell RNA sequencing of sputum cells from nine subjects with CF and five healthy control subjects. We applied novel computational approaches to define expression-based cell function and maturity profiles, herein called transcriptional archetypes.Measurements and Main Results: The airway immune cell repertoire shifted from alveolar macrophages in healthy control subjects to a predominance of recruited monocytes and neutrophils in CF. Recruited lung mononuclear phagocytes were abundant in CF and were separated into the following three archetypes: activated monocytes, monocyte-derived macrophages, and heat shock-activated monocytes. Neutrophils were the most prevalent in CF, with a dominant immature proinflammatory archetype. Although CF monocytes exhibited proinflammatory features, both monocytes and neutrophils showed transcriptional evidence of abnormal phagocytic and cell-survival programs.Conclusions: Our findings offer an opportunity to understand subject-specific immune dysfunction and its contribution to divergent clinical courses in CF. As we progress toward personalized applications of therapeutic and genomic developments, we hope this inflammation-profiling approach will enable further discoveries that change the natural history of CF lung disease.
Rationale: Cystic fibrosis (CF) is a life-shortening, multisystem hereditary disease caused by abnormal chloride transport. CF lung disease is driven by innate immune dysfunction and exaggerated inflammatory responses that contribute to tissue injury. To define the transcriptional profile of this airway immune dysfunction, we performed the first single-cell transcriptome characterization of CF sputum. Objectives: To define the transcriptional profile of sputum cells and its implication in the pathogenesis of immune function and the development of CF lung disease. Methods: We performed single-cell RNA sequencing of sputum cells from nine subjects with CF and five healthy control subjects. We applied novel computational approaches to define expression-based cell function and maturity profiles, herein called transcriptional archetypes.Measurements and Main Results: The airway immune cell repertoire shifted from alveolar macrophages in healthy control subjects to a predominance of recruited monocytes and neutrophils in CF. Recruited lung mononuclear phagocytes were abundant in CF and were separated into the following three archetypes: activated monocytes, monocyte-derived macrophages, and heat shock-activated monocytes. Neutrophils were the most prevalent in CF, with a dominant immature proinflammatory archetype. Although CF monocytes exhibited proinflammatory features, both monocytes and neutrophils showed transcriptional evidence of abnormal phagocytic and cell-survival programs.Conclusions: Our findings offer an opportunity to understand subject-specific immune dysfunction and its contribution to divergent clinical courses in CF. As we progress toward personalized applications of therapeutic and genomic developments, we hope this inflammation-profiling approach will enable further discoveries that change the natural history of CF lung disease.
Authors: Wanda K O'Neal; Paul Gallins; Rhonda G Pace; Hong Dang; Whitney E Wolf; Lisa C Jones; XueLiang Guo; Yi-Hui Zhou; Vered Madar; Jinyan Huang; Liming Liang; Miriam F Moffatt; Garry R Cutting; Mitchell L Drumm; Johanna M Rommens; Lisa J Strug; Wei Sun; Jaclyn R Stonebraker; Fred A Wright; Michael R Knowles Journal: Am J Hum Genet Date: 2015-01-29 Impact factor: 11.025
Authors: Philip A Reid; David A McAllister; A Christopher Boyd; J Alastair Innes; David Porteous; Andrew P Greening; Robert D Gray Journal: Am J Respir Crit Care Med Date: 2015-01-15 Impact factor: 21.405
Authors: Claudio Sorio; Alessio Montresor; Matteo Bolomini-Vittori; Sara Caldrer; Barbara Rossi; Silvia Dusi; Stefano Angiari; Jan E Johansson; Marzia Vezzalini; Teresinha Leal; Elisa Calcaterra; Baroukh M Assael; Paola Melotti; Carlo Laudanna Journal: Am J Respir Crit Care Med Date: 2016-05-15 Impact factor: 21.405
Authors: J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou Journal: Science Date: 1989-09-08 Impact factor: 47.728
Authors: Emanuela M Bruscia; Ping-Xia Zhang; Ayano Satoh; Christina Caputo; Ruslan Medzhitov; Ambika Shenoy; Marie E Egan; Diane S Krause Journal: J Immunol Date: 2011-05-18 Impact factor: 5.422
Authors: Camilla Margaroli; Luke W Garratt; Hamed Horati; A Susanne Dittrich; Timothy Rosenow; Samuel T Montgomery; Dario L Frey; Milton R Brown; Carsten Schultz; Lokesh Guglani; Anthony Kicic; Limin Peng; Bob J Scholte; Marcus A Mall; Hettie M Janssens; Stephen M Stick; Rabindra Tirouvanziam Journal: Am J Respir Crit Care Med Date: 2019-04-01 Impact factor: 21.405
Authors: Pauline B Van de Weert-van Leeuwen; Marit A Van Meegen; Jennifer J Speirs; D J Pals; Suzan H M Rooijakkers; Cornelis K Van der Ent; Suzanne W J Terheggen-Lagro; Hubertus G M Arets; Jeffrey M Beekman Journal: Am J Respir Cell Mol Biol Date: 2013-09 Impact factor: 6.914
Authors: MeiLan K Han; Emilio Arteaga-Solis; John Blenis; Ghada Bourjeily; Deborah J Clegg; Dawn DeMeo; Jeanne Duffy; Ben Gaston; Nicola M Heller; Anna Hemnes; Elizabeth Petri Henske; Raksha Jain; Tim Lahm; Lisa H Lancaster; Joyce Lee; Marianne J Legato; Sherry McKee; Reena Mehra; Alison Morris; Y S Prakash; Martin R Stampfli; Rashmi Gopal-Srivastava; Aaron D Laposky; Antonello Punturieri; Lora Reineck; Xenia Tigno; Janine Clayton Journal: Am J Respir Crit Care Med Date: 2018-10-01 Impact factor: 21.405
Authors: Luigi Grassi; Farzin Pourfarzad; Sebastian Ullrich; Angelika Merkel; Felipe Were; Enrique Carrillo-de-Santa-Pau; Guoqiang Yi; Ida H Hiemstra; Anton T J Tool; Erik Mul; Juliane Perner; Eva Janssen-Megens; Kim Berentsen; Hinri Kerstens; Ehsan Habibi; Marta Gut; Marie Laure Yaspo; Matthias Linser; Ernesto Lowy; Avik Datta; Laura Clarke; Paul Flicek; Martin Vingron; Dirk Roos; Timo K van den Berg; Simon Heath; Daniel Rico; Mattia Frontini; Myrto Kostadima; Ivo Gut; Alfonso Valencia; Willem H Ouwehand; Hendrik G Stunnenberg; Joost H A Martens; Taco W Kuijpers Journal: Cell Rep Date: 2018-09-04 Impact factor: 9.423
Authors: Andrew L Thurman; Xiaopeng Li; Raul Villacreses; Wenjie Yu; Huiyu Gong; Steven E Mather; Guillermo S Romano-Ibarra; David K Meyerholz; David A Stoltz; Michael J Welsh; Ian M Thornell; Joseph Zabner; Alejandro A Pezzulo Journal: Am J Respir Cell Mol Biol Date: 2022-06 Impact factor: 7.748
Authors: Erick Forno; Steven H Abman; Jagdev Singh; Mary E Robbins; Hiran Selvadurai; Paul T Schumacker; Paul D Robinson Journal: Am J Respir Crit Care Med Date: 2021-08-01 Impact factor: 30.528
Authors: Anat Zimmer; Yael Korem; Noa Rappaport; Tomasz Wilmanski; Priyanka Baloni; Kathleen Jade; Max Robinson; Andrew T Magis; Jennifer Lovejoy; Sean M Gibbons; Leroy Hood; Nathan D Price Journal: Nat Commun Date: 2021-06-11 Impact factor: 14.919
Authors: Shuzhong Zhang; Chandra L Shrestha; Benjamin L Wisniewski; Hanh Pham; Xucheng Hou; Wenqing Li; Yizhou Dong; Benjamin T Kopp Journal: Front Immunol Date: 2020-08-18 Impact factor: 7.561